共 15 条
- [1] Shi T(2017)RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study Lancet 390 946-948
- [2] McAllister DA(2017)Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis Eur J Clin Microbiol Infect Dis 36 1057-1062
- [3] O'Brien KL(2000)Epidemiology of respiratory syncytial virus infection in Southern Austria Pediatr Infect Dis J 19 587-588
- [4] Resch B(2002)The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years Infection 30 193-197
- [5] Bramreiter VS(2014)Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection Pediatrics 134 e620-e638
- [6] Kurath-Koller S(undefined)undefined undefined undefined undefined-undefined
- [7] Freidl T(undefined)undefined undefined undefined undefined-undefined
- [8] Urlesberger B(undefined)undefined undefined undefined undefined-undefined
- [9] Resch B(undefined)undefined undefined undefined undefined-undefined
- [10] Gusenleitner W(undefined)undefined undefined undefined undefined-undefined